Protein clue could stop cancer 'creep'

NewsGuard 100/100 Score

Cancer Research UK scientists have unlocked the secrets of proteins involved in tumour cells creeping away from the original tumour and spreading around the body. Their findings are published in Molecular Cell.

The study involves a protein called Tes which appears to block cell growth and prevent tumours from forming. Scientists have now shown that it locks onto Mena - a protein involved in cell crawling that is found in excessive amounts in tumours.

This is exciting because Tes binds to Mena in an unexpected way compared with other proteins that interact with Mena.

Crucially, when Tes binds to Mena, it stops cells from crawling as it blocks Mena from sticking to its usual binding partners.

The discovery offers the possibility of the development of drugs which could block the action of Mena by mimicking the action of Tes.

The movement of cells from the primary tumour to other parts of the body is the main reason that cancer can be so difficult to treat. Preventing this is one of the major challenges for researchers.

Dr Michael Way, lead author based at Cancer Research UK's London Research Institute, said: "Our findings represent a new way to regulate of a key family of proteins involved in cell crawling that will change the way researchers see current models of cell migration - an important aspect of the spread of cancer."

Dr Lesley Walker, director of science information at Cancer Research UK, said: "Cancer cells use many complex processes when they break away from their tumour and spread to other areas of the body. Understanding these mechanisms and increasing our knowledge about this protein can hopefully help us to develop more effective cancer treatments in the future."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis